Sensei Biotherapeutics, Inc. (SNSE)
30.49
+1.27
(+4.35%)
USD |
NASDAQ |
Apr 17, 16:00
30.81
+0.32
(+1.05%)
After-Hours: 20:00
Sensei Biotherapeutics Research and Development Expense (Quarterly) : 2.536M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.527B |
| Vir Biotechnology, Inc. | 85.53M |
| Acurx Pharmaceuticals, Inc. | 0.2818M |
| Tango Therapeutics, Inc. | 31.62M |
| Xilio Therapeutics, Inc. | 18.12M |